Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Use of a Motorlance to Deliver Emergency Medical Services; a Prospective Cross Sectional Study.

Apiratwarakul K, Ienghong K, Mitsungnern T, Kotruchin P, Phungoen P, Bhudhisawasdi V.

Arch Acad Emerg Med. 2019 Aug 21;7(1):e48. eCollection 2019.

PMID:
31602431
2.

Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct.

Luvira V, Kamsa-Ard S, Pugkhem A, Luvira V, Srisuk T, Titapun A, Silsirivanit A, Wongkham S, Khuntikeo N, Pairojkul C, Bhudhisawasdi V.

Clin Exp Hepatol. 2019 Sep;5(3):250-255. doi: 10.5114/ceh.2019.87641. Epub 2019 Sep 5.

PMID:
31598563
3.

Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma.

Haznadar M, Diehl CM, Parker AL, Krausz KW, Bowman ED, Rabibhadana S, Forgues M, Bhudhisawasdi V, Gonzalez FJ, Mahidol C, Budhu A, Wang XW, Ruchirawat M, Harris CC.

Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1704-1711. doi: 10.1158/1055-9965.EPI-19-0453. Epub 2019 Jul 29.

PMID:
31358519
4.

Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.

Vaeteewoottacharn K, Pairojkul C, Kariya R, Muisuk K, Imtawil K, Chamgramol Y, Bhudhisawasdi V, Khuntikeo N, Pugkhem A, Saeseow OT, Silsirivanit A, Wongkham C, Wongkham S, Okada S.

Cells. 2019 May 23;8(5). pii: E496. doi: 10.3390/cells8050496.

5.

The Curious Case of Cholangiocarcinoma: Opportunities for Environmental Health Scientists to Learn about a Complex Disease.

Suk WA, Bhudhisawasdi V, Ruchirawat M.

J Environ Public Health. 2018 Aug 9;2018:2606973. doi: 10.1155/2018/2606973. eCollection 2018. Review.

6.

Association between Repeated Praziquantel treatment and Papillary, and Intrahepatic Cholangiocarcinoma.

Luvira V, Kamsa-Ard S, Kamsa-Ard S, Luvira V, Srisuk T, Pugkhem A, Pairojkul C, Bhudhisawasdi V.

Ann Hepatol. 2018 Aug 24;17(5):802-809. doi: 10.5604/01.3001.0012.3140.

7.

Cholangiocarcinoma Trends, Incidence, and Relative Survival in Khon Kaen, Thailand From 1989 Through 2013: A Population-Based Cancer Registry Study.

Kamsa-Ard S, Luvira V, Suwanrungruang K, Kamsa-Ard S, Luvira V, Santong C, Srisuk T, Pugkhem A, Bhudhisawasdi V, Pairojkul C.

J Epidemiol. 2019 May 5;29(5):197-204. doi: 10.2188/jea.JE20180007. Epub 2018 Aug 4.

8.

Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI-PEG20 treatment in CCA cell lines.

Roeksomtawin S, Navasumrit P, Waraprasit S, Parnlob V, Sricharunrat T, Bhudhisawasdi V, Savaraj N, Ruchirawat M.

Oncol Lett. 2018 Aug;16(2):1529-1538. doi: 10.3892/ol.2018.8807. Epub 2018 May 24.

9.

Papillomatosis of the Biliary Tree and Gallbladder: Successful Treatment With Repeated Resection and Liver Transplant.

Luvira V, Pugkhem A, Bhudhisawasdi V, Uttaravichien TU, Sripanuskul A, Pongskul J, Pairojkul C.

Exp Clin Transplant. 2019 Oct;17(5):688-691. doi: 10.6002/ect.2017.0121. Epub 2017 Dec 5.

10.

Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis.

Thuwajit C, Thuwajit P, Jamjantra P, Pairojkul C, Wongkham S, Bhudhisawasdi V, Ono J, Ohta S, Fujimoto K, Izuhara K.

Oncol Lett. 2017 Jul;14(1):623-634. doi: 10.3892/ol.2017.6250. Epub 2017 May 25.

11.

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.

Jusakul A, Cutcutache I, Yong CH, Lim JQ, Huang MN, Padmanabhan N, Nellore V, Kongpetch S, Ng AWT, Ng LM, Choo SP, Myint SS, Thanan R, Nagarajan S, Lim WK, Ng CCY, Boot A, Liu M, Ong CK, Rajasegaran V, Lie S, Lim AST, Lim TH, Tan J, Loh JL, McPherson JR, Khuntikeo N, Bhudhisawasdi V, Yongvanit P, Wongkham S, Totoki Y, Nakamura H, Arai Y, Yamasaki S, Chow PK, Chung AYF, Ooi LLPJ, Lim KH, Dima S, Duda DG, Popescu I, Broet P, Hsieh SY, Yu MC, Scarpa A, Lai J, Luo DX, Carvalho AL, Vettore AL, Rhee H, Park YN, Alexandrov LB, Gordân R, Rozen SG, Shibata T, Pairojkul C, Teh BT, Tan P.

Cancer Discov. 2017 Oct;7(10):1116-1135. doi: 10.1158/2159-8290.CD-17-0368. Epub 2017 Jun 30.

12.

Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.

Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon SM, Forgues M, Pomyen Y, Bhudhisawasdi V, Lertprasertsuke N, Chotirosniramit A, Pairojkul C, Auewarakul CU, Sricharunrat T, Phornphutkul K, Sangrajrang S, Cam M, He P, Hewitt SM, Ylaya K, Wu X, Andersen JB, Thorgeirsson SS, Waterfall JJ, Zhu YJ, Walling J, Stevenson HS, Edelman D, Meltzer PS, Loffredo CA, Hama N, Shibata T, Wiltrout RH, Harris CC, Mahidol C, Ruchirawat M, Wang XW; TIGER-LC Consortium.

Cancer Cell. 2017 Jul 10;32(1):57-70.e3. doi: 10.1016/j.ccell.2017.05.009. Epub 2017 Jun 22.

13.

The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma.

Thongkum A, Wu C, Li YY, Wangpaichitr M, Navasumrit P, Parnlob V, Sricharunrat T, Bhudhisawasdi V, Ruchirawat M, Savaraj N.

Int J Mol Sci. 2017 Jun 1;18(6). pii: E1175. doi: 10.3390/ijms18061175.

14.

Prognostic Factors for Large Symptomatic Gists: a Pragmatic Study of Experiences From a University Hospital Over 10 Years

Prasertcharoensuk S, Thanapongpornthana P, Bhudhisawasdi V, Pugkhem A, Jenwitheesuk K, Sookprasert A, Pairojkul Ch.

Asian Pac J Cancer Prev. 2017 Mar 1;18(3):655-658.

15.

Morphological Classification of Intraductal Papillary Neoplasm of the Bile Duct with Survival Correlation

Luvira V, Somsap K, Pugkhem A, Eurboonyanun Ch, Luvira V, Bhudhisawasdi V, Pairojkul Ch, Kamsa Ard S.

Asian Pac J Cancer Prev. 2017 Jan 1;18(1):207-213.

16.

Patterns of Recurrence after Resection of Mass-Forming Type Intrahepatic Cholangiocarcinomas

Luvira V, Eurboonyanun Ch, Bhudhisawasdi V, Pugkhem A, Pairojkul Ch, Luvira V, Sathitkarnmanee E, Somsap K, Kamsa-ard S.

Asian Pac J Cancer Prev. 2016 Oct 1;17(10):4735-4739.

17.

Association between Pesticide Use and Cholangiocarcinoma.

Jeephet K, Kamsa-Ard S, Bhudhisawasdi V, Kamsa-Ard S, Luvira V, Luvira V.

Asian Pac J Cancer Prev. 2016;17(8):3979-82.

18.

Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma.

Chng KR, Chan SH, Ng AHQ, Li C, Jusakul A, Bertrand D, Wilm A, Choo SP, Tan DMY, Lim KH, Soetinko R, Ong CK, Duda DG, Dima S, Popescu I, Wongkham C, Feng Z, Yeoh KG, Teh BT, Yongvanit P, Wongkham S, Bhudhisawasdi V, Khuntikeo N, Tan P, Pairojkul C, Ngeow J, Nagarajan N.

EBioMedicine. 2016 Jun;8:195-202. doi: 10.1016/j.ebiom.2016.04.034. Epub 2016 May 6.

19.

Long-term outcome of surgical resection for intraductal papillary neoplasm of the bile duct.

Luvira V, Pugkhem A, Bhudhisawasdi V, Pairojkul C, Sathitkarnmanee E, Luvira V, Kamsa-Ard S.

J Gastroenterol Hepatol. 2017 Feb;32(2):527-533. doi: 10.1111/jgh.13481.

PMID:
27356284
20.

Simultaneous Extensive Intraductal Papillary Neoplasm of the Bile Duct and Pancreas: A Very Rare Entity.

Luvira V, Pugkhem A, Tipwaratorn T, Chamgramol Y, Pairojkul C, Bhudhisawasdi V.

Case Rep Surg. 2016;2016:1518707. doi: 10.1155/2016/1518707. Epub 2016 Jan 26.

21.

Cholangiocarcinoma Patient Outcome in Northeastern Thailand: Single-Center Prospective Study.

Luvira V, Nilprapha K, Bhudhisawasdi V, Pugkhem A, Chamadol N, Kamsa-ard S.

Asian Pac J Cancer Prev. 2016;17(1):401-6.

22.

Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study.

Kamsa-Ard S, Luvira V, Pugkhem A, Luvira V, Thinkhamrop B, Suwanrungruang K, Bhudhisawasdi V.

BMC Cancer. 2015 Oct 24;15:776. doi: 10.1186/s12885-015-1788-6.

23.

The miRNAome of Opisthorchis viverrini induced intrahepatic cholangiocarcinoma.

Peng J, Feng Y, Rinaldi G, Yonglitthipagon P, Easley SE, Laha T, Pairojkul C, Bhudhisawasdi V, Sripa B, Brindley PJ, Mulvenna JP, Bethony JM, Plieskatt JL.

Genom Data. 2014 Aug 28;2:274-9. doi: 10.1016/j.gdata.2014.08.007. eCollection 2014 Dec.

24.

A microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma.

Plieskatt J, Rinaldi G, Feng Y, Peng J, Easley S, Jia X, Potriquet J, Pairojkul C, Bhudhisawasdi V, Sripa B, Brindley PJ, Bethony J, Mulvenna J.

BMC Cancer. 2015 Apr 23;15:309. doi: 10.1186/s12885-015-1270-5.

25.

Distinct miRNA signatures associate with subtypes of cholangiocarcinoma from infection with the tumourigenic liver fluke Opisthorchis viverrini.

Plieskatt JL, Rinaldi G, Feng Y, Peng J, Yonglitthipagon P, Easley S, Laha T, Pairojkul C, Bhudhisawasdi V, Sripa B, Brindley PJ, Mulvenna JP, Bethony JM.

J Hepatol. 2014 Oct;61(4):850-8. doi: 10.1016/j.jhep.2014.05.035. Epub 2014 Jun 3.

PMID:
25017828
26.

Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience.

Khuntikeo N, Pugkhem A, Titapun A, Bhudhisawasdi V.

J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):521-4. doi: 10.1002/jhbp.74. Epub 2014 Jan 27. Review.

PMID:
24464976
27.

Potential targeted therapy for liver fluke associated cholangiocarcinoma.

Vaeteewoottacharn K, Seubwai W, Bhudhisawasdi V, Okada S, Wongkham S.

J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):362-70. doi: 10.1002/jhbp.65. Epub 2014 Jan 10. Review.

PMID:
24408866
28.

Association between praziquantel and cholangiocarcinoma in patients infected with Opisthorchis viverrini: a systematic review and meta-analysis.

Kamsa-ard S, Laopaiboon M, Luvira V, Bhudhisawasdi V.

Asian Pac J Cancer Prev. 2013;14(11):7011-6. Review.

29.

Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.

Chan-On W, Nairismägi ML, Ong CK, Lim WK, Dima S, Pairojkul C, Lim KH, McPherson JR, Cutcutache I, Heng HL, Ooi L, Chung A, Chow P, Cheow PC, Lee SY, Choo SP, Tan IB, Duda D, Nastase A, Myint SS, Wong BH, Gan A, Rajasegaran V, Ng CC, Nagarajan S, Jusakul A, Zhang S, Vohra P, Yu W, Huang D, Sithithaworn P, Yongvanit P, Wongkham S, Khuntikeo N, Bhudhisawasdi V, Popescu I, Rozen SG, Tan P, Teh BT.

Nat Genet. 2013 Dec;45(12):1474-8. doi: 10.1038/ng.2806. Epub 2013 Nov 3.

PMID:
24185513
30.

Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia.

Qin S, Bai Y, Lim HY, Thongprasert S, Chao Y, Fan J, Yang TS, Bhudhisawasdi V, Kang WK, Zhou Y, Lee JH, Sun Y.

J Clin Oncol. 2013 Oct 1;31(28):3501-8. doi: 10.1200/JCO.2012.44.5643. Epub 2013 Aug 26.

PMID:
23980077
31.

Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.

Yothaisong S, Dokduang H, Techasen A, Namwat N, Yongvanit P, Bhudhisawasdi V, Puapairoj A, Riggins GJ, Loilome W.

Tumour Biol. 2013 Dec;34(6):3637-48. doi: 10.1007/s13277-013-0945-2. Epub 2013 Jul 6.

PMID:
23832540
32.

Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil.

Hahnvajanawong C, Chaiyagool J, Seubwai W, Bhudhisawasdi V, Namwat N, Khuntikeo N, Sripa B, Pugkhem A, Tassaneeyakul W.

World J Gastroenterol. 2012 Aug 14;18(30):3955-61. doi: 10.3748/wjg.v18.i30.3955.

33.

Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini.

Sripa B, Thinkhamrop B, Mairiang E, Laha T, Kaewkes S, Sithithaworn P, Periago MV, Bhudhisawasdi V, Yonglitthipagon P, Mulvenna J, Brindley PJ, Loukas A, Bethony JM.

PLoS Negl Trop Dis. 2012;6(5):e1654. doi: 10.1371/journal.pntd.0001654. Epub 2012 May 22.

34.

Exome sequencing of liver fluke-associated cholangiocarcinoma.

Ong CK, Subimerb C, Pairojkul C, Wongkham S, Cutcutache I, Yu W, McPherson JR, Allen GE, Ng CC, Wong BH, Myint SS, Rajasegaran V, Heng HL, Gan A, Zang ZJ, Wu Y, Wu J, Lee MH, Huang D, Ong P, Chan-on W, Cao Y, Qian CN, Lim KH, Ooi A, Dykema K, Furge K, Kukongviriyapan V, Sripa B, Wongkham C, Yongvanit P, Futreal PA, Bhudhisawasdi V, Rozen S, Tan P, Teh BT.

Nat Genet. 2012 May 6;44(6):690-3. doi: 10.1038/ng.2273.

PMID:
22561520
35.

Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma.

Yonglitthipagon P, Pairojkul C, Bhudhisawasdi V, Mulvenna J, Loukas A, Sripa B.

Clin Biochem. 2012 Jul;45(10-11):827-34. doi: 10.1016/j.clinbiochem.2012.04.004. Epub 2012 Apr 19. Retraction in: Clin Biochem. 2016 Jan;49(1-2):196.

36.

Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma.

Yonglitthipagon P, Pairojkul C, Chamgramol Y, Loukas A, Mulvenna J, Bethony J, Bhudhisawasdi V, Sripa B.

Hum Pathol. 2012 Oct;43(10):1719-30. doi: 10.1016/j.humpath.2011.11.021. Epub 2012 Mar 24.

37.

Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation.

Boonyanugomol W, Chomvarin C, Sripa B, Bhudhisawasdi V, Khuntikeo N, Hahnvajanawong C, Chamsuwan A.

HPB (Oxford). 2012 Mar;14(3):177-84. doi: 10.1111/j.1477-2574.2011.00423.x. Epub 2012 Jan 10.

38.

Evaluation of postoperative adjuvant chemotherapy for intrahepatic cholangiocarcinoma patients undergoing R1 and R2 resections.

Bhudhisawasdi V, Talabnin C, Pugkhem A, Khuntikeo N, Seow OT, Chur-in S, Pairojkul C, Wongkham S.

Asian Pac J Cancer Prev. 2012;13 Suppl:169-74.

39.

Evaluation of efficacy, safety and tolerability of high dose-intermittent calcitriol supplementation to advanced intrahepatic cholangiocarcinoma patients--a pilot study.

Sookprasert A, Pugkhem A, Khuntikeo N, Chur-in S, Chamadol N, Prawan A, Janeklang S, Vaeteewoottacharn K, Kukongviriyapan V, Pairojkul C, Bhudhisawasdi V, Wongkham S.

Asian Pac J Cancer Prev. 2012;13 Suppl:161-7.

40.

Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma.

Jusakul A, Khuntikeo N, Haigh WG, Kuver R, Ioannou GN, Loilome W, Namwat N, Bhudhisawasdi V, Pugkhem A, Pairojkul C, Yongvanit P.

Asian Pac J Cancer Prev. 2012;13 Suppl:77-82.

41.

Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma.

Boonjaraspinyo S, Wu Z, Boonmars T, Kaewkes S, Loilome W, Sithithaworn P, Nagano I, Takahashi Y, Yongvanit P, Bhudhisawasdi V.

Parasitol Int. 2012 Mar;61(1):145-50. doi: 10.1016/j.parint.2011.07.008. Epub 2011 Jul 14.

PMID:
21777692
42.

Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma.

Boonjaraspinyo S, Boonmars T, Kaewkes S, Laummaunwai P, Pinlaor S, Loilome W, Yongvanit P, Wu Z, Puapairoj A, Bhudhisawasdi V.

Pathol Oncol Res. 2012 Apr;18(2):227-37. doi: 10.1007/s12253-011-9432-5. Epub 2011 Jul 13.

PMID:
21750953
43.

Acute pancreatitis: assessment severity with Ranson score and CT evaluation.

Aphinives P, Karunasumetta C, Bhudhisawasdi V, Saesaew OT.

J Med Assoc Thai. 2011 Apr;94(4):437-40.

PMID:
21591528
44.

Breast cancer: five-year survival in Srinagarind Hospital, Thailand.

Aphinives P, Punchai S, Vajirodom D, Bhudhisawasdi V.

J Med Assoc Thai. 2010 Mar;93 Suppl 3:S25-9.

PMID:
21299088
45.

PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma.

Loilome W, Juntana S, Namwat N, Bhudhisawasdi V, Puapairoj A, Sripa B, Miwa M, Saya H, Riggins GJ, Yongvanit P.

Int J Cancer. 2011 Jul 1;129(1):34-44. doi: 10.1002/ijc.25646. Epub 2010 Nov 3.

46.

Comparison of computed tomographic finding of the intraductal and periductal cholangiocarcinoma.

Chamadol N, Laopaiboon V, Kaewradee J, Khuntikeo N, Bhudhisawasdi V, Pairojkul C.

J Med Assoc Thai. 2010 Apr;93(4):481-8.

PMID:
20462093
47.

Genetic and epigenetic alterations of RIZ1 and the correlation to clinicopathological parameters in liver fluke-related cholangiocarcinoma.

Khaenam P, Jearanaikoon P, Pairojkul C, Bhudhisawasdi V, Limpaiboon T.

Exp Ther Med. 2010 Mar;1(2):385-390. Epub 2010 Mar 1.

48.

Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes.

Srisomsap C, Sawangareetrakul P, Subhasitanont P, Chokchaichamnankit D, Chiablaem K, Bhudhisawasdi V, Wongkham S, Svasti J.

J Biomed Biotechnol. 2010;2010:437143. doi: 10.1155/2010/437143. Epub 2009 Dec 27.

49.

Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.

Chinnasri P, Pairojkul C, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tantimavanich S, Limpaiboon T.

Hum Pathol. 2009 Jun;40(6):817-26. doi: 10.1016/j.humpath.2008.11.002. Epub 2009 Feb 5.

PMID:
19200577
50.

Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines.

Namwat N, Amimanan P, Loilome W, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tassaneeyakul W.

Chemotherapy. 2008;54(5):343-51. doi: 10.1159/000151541. Epub 2008 Aug 21.

PMID:
18714155

Supplemental Content

Loading ...
Support Center